Gist Med
Gist Med38
About
What does Gist Med do?
GistMD provides a proprietary platform that creates personalized, interactive video content to empower patients with healthcare information. This technology improves patient engagement and health literacy by tailoring content to individual needs, leading to better treatment adherence and outcomes. The platform serves healthcare providers by adapting to various clinical settings and reducing staff workload.
What is Gist Med's revenue?
StartupHub estimates Gist Med's annual revenue at $3.5M (range $2.1M to $8.0M, 68% confidence), based on comparable companies in the sector.
Where is Gist Med headquartered?
Gist Med is headquartered in New York, United States.
When was Gist Med founded?
Gist Med was founded in 2017.
What industry does Gist Med operate in?
Gist Med operates in Healthcare, Patient Engagement, HealthTech, Digital Health, MedTech, Personalized Medicine.
How many employees does Gist Med have?
Gist Med has approximately 19 people on record.
AI-powered platform for healthcare providers to manage patient WhatsApp messages efficiently.
AI care management platform for autism and developmental care organizations, improving engagement and family outcomes.
Webwala.ai finds new patients, brings old ones back, and shows you exactly which patients your website brought in. Built for Indian clinics.
Data8 provides a personalized health app built on blockchain technology for secure medical data storage and sharing.
Less keyboard, more patient. The clinical copilot that returns the joy of medicine to your practice.
Digital prescriptions on WhatsApp, automated follow-ups, and AI after-hours assistant for aesthetic and dermatology clinics.
An entrant is a company tagged Patient Engagement whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.